$ARCT News

Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript

Arcturus Therapeutics Holdings (NASDAQ:ARCT) Q1 2026 Results: Revenue Miss Weighs on Sentiment as Pipeline Advances

Arcturus Therapeutics Holdings Appoints Dennis Mulroy As CFO Effective May 1, 2026

Arcturus Therapeutics Q1 EPS $(0.95) Beats $(1.00) Estimate, Sales $2.061M Miss $7.233M Estimate

B. Riley Securities Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces Price Target of $22

Demystifying Arcturus Therapeutics: Insights From 4 Analyst Reviews

Citigroup Maintains Buy on Arcturus Therapeutics, Lowers Price Target to $21

Citigroup Maintains Neutral on Arcturus Therapeutics, Raises Price Target to $8

Piper Sandler Maintains Overweight on Arcturus Therapeutics, Lowers Price Target to $25

Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call Transcript

Arcturus Therapeutics (NASDAQ:ARCT) Stock Falls After Q4 2025 Revenue Miss

Arcturus Therapeutics Q4 Earnings Assessment

Arcturus Therapeutics Q4 EPS $(1.03) Misses $(0.98) Estimate, Sales $7.196M Miss $17.669M Estimate

Arcturus Therapeutics Q4 EPS $(1.03) Misses $(0.98) Estimate, Sales $7.196M Miss $17.669M Estimate

Earnings Preview: Arcturus Therapeutics

Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure

Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets

Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presentation Nears

Arcturus Therapeutics Maps Near-Term Milestones for CF mRNA Therapy, ARCT-810 at J.P. Morgan Conference

Is Arcturus Therapeutics (ARCT) Using Its $500 Million Shelf to Redefine Capital Strategy?